Late-onset myasthenia not on the increase: A nationwide register study in Denmark, 1996-2009

European Journal of Neurology

Volumn 20, Issue 2, 2013, Pages 309-314

  Pedersen, E G ^a,b   Hallas, J ^c   Hansen, K ^d   Jensen, P E H ^d   Gaist, D ^a,b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d Rigshospitalet   (Denmark)

Author keywords

Epidemiology; Incidence; Myasthenia

Indexed keywords

PYRIDOSTIGMINE;

ADULT; AGED; ALGORITHM; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DENMARK; FEMALE; HUMAN; INCIDENCE; LATE ONSET MYASTHENIA GRAVIS; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; ONSET AGE; POPULATION BASED CASE CONTROL STUDY; PRESCRIPTION; PRIORITY JOURNAL; REGISTER; SEX RATIO;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DENMARK; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; REGISTRIES;

EID: 84872395198     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2012.03850.x     Document Type: Article

References (18)

1. Meriggioli MN, Sanders DB. Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol 2009; 8: 475-490.
2. Aragonès JM, Bolíbar I, Bonfill X, Mummary A, Alonso F, Illa I. Myasthenia gravis. A higher than expected incidence in the elderly. Neurology 2003; 60: 1024-1026.
3. Matsuda M, Dohi-Iijima N, Nakamura A, et al. Increase in incidence of elderly-onset patients with myasthenia gravis in Nagano Prefecture, Japan. Intern Med 2005; 44: 572-577.
4. Somnier FE. Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia. Neurology 2005; 65: 928-930.
5. Pakzad Z, Aziz T, Oger J. Increasing incidence of myasthenia gravis among elderly in British Columbia, Canada. Neurology 2011; 76: 1526-1528.
6. Casetta I, Groppo E, De Gennaro R, et al. Myasthenia gravis: a changing pattern of incidence. J Neurol 2010; 257: 2015-2019.
7. Vincent A, Clover L, Buckley C, Grimley Evans J, Rothwell PM, UK Myasthenia Gravis Survey. Evidence of underdiagnosis of myasthenia gravis in older people. J Neurol Neurosurg Psychiatry 2003; 74: 1105-1108.
8. Pedersen EG, Hallas J, Hansen K, Jensen PE, Gaist D. Identifying patients with myasthenia for epidemiological research by linkage of automated registers. Neuroepidemiology 2011; 37: 120-128.
9. Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health 2011; 39(7 Suppl.): 30-33.
10. Kildemoes HW, Sørensen HT, Hallas J. The Danish National Prescription Registry. Scand J Public Health 2011; 39(7 Suppl.): 38-41.
11. WHO Collaborating Centre for Drug Statistics Methodology. Anatomical Therapeutic Chemical (ATC) Classification Index with Defined Daily Doses (DDDs). Oslo, Norway: WHO, 2000.
12. Pedersen CB. The Danish Civil Registration System. Scand J Public Health 2011; 39(7 Suppl.): 22-25.
13. Morris JA, Gardner MJ. Calculating confidence intervals for relative risks (odds ratios) and standardised ratios and rates. Br Med J 1988; 296: 1313-1316.
14. Matsui N, Nakane S, Nakagawa Y, et al. Increasing incidence of elderly onset patients with myasthenia gravis in a local area of Japan. J Neurol Neurosurg Psychiatry 2009; 80: 1168-1171.
15. Carr AS, Cardwell CR, McCarron PO, McConville J. A systematic review of population based epidemiological studies in myasthenia gravis. BMC Neurol 2010; 10: 46.
16. Heldal AT, Eide GE, Gilhus NE, Romi F. Geographical distribution of a seropositive myasthenia gravis population. Muscle Nerve 2012; 45: 815-819.
17. Grob D, Arsura EL, Brunner NG, Namba T. The course of myasthenia gravis and therapies affecting outcome. Ann N Y Acad Sci 1987; 505: 472-499. Review.
18. Kaminski HJ. Myasthenia Gravis and Related Disorders, 2nd edn. St Louis: Humana Press, 2009: 79-94.